CINECA IRIS Institutional Research Information System

VOENA, Claudia
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.062
EU - Europa 1.988
AS - Asia 1.129
SA - Sud America 71
AF - Africa 34
OC - Oceania 9
Continente sconosciuto - Info sul continente non disponibili 1
Totale 6.294
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.024
CN - Cina 577
IT - Italia 496
SG - Singapore 285
SE - Svezia 236
DE - Germania 207
IE - Irlanda 206
FI - Finlandia 154
UA - Ucraina 150
DK - Danimarca 144
FR - Francia 133
AT - Austria 79
KR - Corea 68
BR - Brasile 61
GB - Regno Unito 52
IN - India 38
PL - Polonia 38
JP - Giappone 36
VN - Vietnam 36
CA - Canada 32
BE - Belgio 26
SN - Senegal 24
HK - Hong Kong 23
ID - Indonesia 18
ES - Italia 16
RU - Federazione Russa 14
TR - Turchia 12
NL - Olanda 11
TW - Taiwan 10
AU - Australia 9
AE - Emirati Arabi Uniti 6
RO - Romania 6
MX - Messico 5
PT - Portogallo 5
AR - Argentina 4
CZ - Repubblica Ceca 3
MA - Marocco 3
NO - Norvegia 3
PE - Perù 3
AM - Armenia 2
BD - Bangladesh 2
BY - Bielorussia 2
CH - Svizzera 2
EG - Egitto 2
GR - Grecia 2
LT - Lituania 2
MY - Malesia 2
NG - Nigeria 2
SA - Arabia Saudita 2
TH - Thailandia 2
UZ - Uzbekistan 2
CG - Congo 1
CO - Colombia 1
DO - Repubblica Dominicana 1
EU - Europa 1
IL - Israele 1
IQ - Iraq 1
IR - Iran 1
KE - Kenya 1
KW - Kuwait 1
KZ - Kazakistan 1
LU - Lussemburgo 1
MO - Macao, regione amministrativa speciale della Cina 1
PH - Filippine 1
PK - Pakistan 1
PY - Paraguay 1
TN - Tunisia 1
VE - Venezuela 1
Totale 6.294
Salva come PNG Salva come JPEG
Città #
Chandler 399
Beijing 318
Santa Clara 258
Ann Arbor 215
Dublin 206
Singapore 206
Houston 149
Fairfield 148
Torino 138
Ashburn 135
Turin 123
Wilmington 103
Jacksonville 102
Villeurbanne 89
Nyköping 85
Munich 80
Medford 72
Vienna 72
Woodbridge 71
Princeton 62
Dearborn 61
Cambridge 58
Columbus 58
Seattle 58
Helsinki 52
Fremont 45
Pisa 38
Warsaw 33
Shanghai 32
Boston 25
San Mateo 24
Pune 23
Guangzhou 22
Brussels 21
Dong Ket 21
Redwood City 21
Norwalk 19
Milan 18
Boardman 17
Chieri 16
Jakarta 16
Nanjing 16
Hangzhou 13
Hong Kong 13
Tokyo 13
Chengdu 12
Rome 12
San Diego 11
Toronto 11
Grafing 10
Jülich 9
Los Angeles 9
Washington 9
New York 8
Ottawa 8
Duncan 7
Silver Spring 7
Taipei 7
Verona 7
Bologna 6
Hefei 6
Jyväskylä 6
Nuremberg 6
Central 5
Changsha 5
Düsseldorf 5
El Paso 5
Falls Church 5
Jinan 5
Lissone 5
London 5
Mountain View 5
Occimiano 5
Stockholm 5
Tappahannock 5
Wuhan 5
Baotou 4
Chongqing 4
Falkenstein 4
Hebei 4
Kunming 4
Lachine 4
Lanzhou 4
Nanchang 4
Palermo 4
Phoenix 4
Raritan 4
São Paulo 4
Upper Marlboro 4
Valdagno 4
Zhengzhou 4
Ahmedabad 3
Amsterdam 3
Aurora 3
Berlin 3
Buffalo 3
Catania 3
Council Bluffs 3
Genoa 3
Göttingen 3
Totale 4.067
Salva come PNG Salva come JPEG
Nome #
A theranostic approach based on the use of a dual boron/Gd agent to improve the efficacy of Boron Neutron Capture Therapy in the lung cancer treatment 395
Phosphatidylinositol 3-kinase δ blockade increases genomic instability in B cells 390
Excess of NPM-ALK oncogenic signaling promotes cellular apoptosis and drug dependency 259
p130Cas mediates the transforming properties of the anaplastic lymphoma kinase 255
The anaplastic lymphoma kinase controls cell shape and growth of anaplastic large cell lymphoma through Cdc42 activation 236
Efficacy of a Cancer Vaccine against ALK-Rearranged Lung Tumors 231
Redundant and non-redundant roles for Cdc42 and Rac1 in lymphomas developed in NPM-ALK transgenic mice 202
Modulation of doxorubicin resistance by the glucose 6-phosphate dehydrogenase activity 167
Maternal immunization: New perspectives on its application against non-infectious related diseases in newborns 149
The EGFR family members sustain the neoplastic phenotype of ALK+ lung adenocarcinoma via EGR1. 141
Anaplastic lymphoma kinase in human cancer 131
Detection of minimal residual disease by real-time PCR can be used as a surrogate marker to evaluate the graft-versus-myeloma effect after allogeneic stem cell transplantation. 121
The enzymatic activity of 5-aminoimidazole-4-carboxamide ribonucleotide formyltransferase/IMP cyclohydrolase is enhanced by NPM-ALK: new insights in ALK-mediated pathogenesis and the treatment of ALCL 120
Evidence for a bone marrow B cell transcribing malignant plasma cell VDJ joined to C mu sequence in immunoglobulin IgG and IgA secreting multiple myelomas 118
Wiskott–Aldrich syndrome protein (WASP) is a tumor suppressor in T cell lymphoma 118
Oncogenic ALK regulates EMT in non-small cell lung carcinoma through repression of the epithelial splicing regulatory protein 1 114
Tyrosine phosphatases regulate resistance to ALK inhibitors in ALK+ anaplastic large cell lymphoma 114
Involvement of Grb2 adaptor protein in nucleophosmin-anaplastic lymphoma kinase (NPM-ALK)-mediated signaling and anaplastic large cell lymphoma growth. 113
Detection of circulating tumor cells in multiple myeloma by a PCR-based method. 111
Idiotype vaccination in human myeloma: generation of tumor-specific immune responses after high-dose chemotherapy. 111
BRAF gene is not mutated in plasma cell leukemia and multiple myeloma 100
ALK-dependent control of hypoxia-inducible factors mediates tumor growth and metastasis 99
A novel nested-PCR strategy for the detection of rearranged immunoglobulin heavy-chain genes in B cell tumors. 99
Clinical and molecular remission after allogeneic blood cell transplantation in a patient with mantle-cell lymphoma. 94
RhoA silencing reverts the resistance to doxorubicin in human colon cancer cells 88
NPM-ALK oncogenic tyrosine kinase controls T-cell identity by transcriptional regulation and epigenetic silencing in lymphoma cells 87
Molecular monitoring of minimal residual disease in follicular and mantle cell non-Hodgkin's lymphomas treated with high-dose chemotherapy and peripheral blood progenitor cell autografting. 87
The mutation of N-ras oncogene does not involve myeloid and erythroid lineages in a case of multiple myeloma. 87
Molecular purging of multiple myeloma cells by ex-vivo culture and retroviral transduction of mobilized-blood CD34+ cells 85
Targeting hif-1α regulatory pathways as a strategy to hamper tumor-microenvironment interactions in cll 82
Epitope mapping of spontaneous autoantibodies to anaplastic lymphoma kinase (ALK) in non-small cell lung cancer 80
Advances in cancer immunology and cancer immunotherapy 79
Liposomal doxorubicin reverses drug-resistance by inhibiting P-glycoprotein in human cancer cells 78
Development of a consensus IgH quantitative assay for the detection of minimal residual disease in Chronic Lymphocytic Leukemia using 3’-minor groove binder probes. 76
High-dose sequential chemoradiotherapy in multiple myeloma: residual tumor cells are detectable in bone marrow and peripheral blood cell harvests and after autografting. 75
LIGHT/TNFSF14 Promotes Osteolytic Bone Metastases in Non-small Cell Lung Cancer Patients 75
The tyrosine phosphatase Shp2 interacts with NPM-ALK and regulates anaplastic lymphoma cell growth and migration 74
The anaplastic lymphoma kinase as an oncogene in solid tumors 74
PCR-detectable non-neoplastic Bcl-2/IgH rearrangements are common in normal subjects and cancer patients at diagnosis, but rare in subjects treated with chemotherapy. 73
Inactivation of tumor suppressor genes, p53 and Rb1, in plasma cell dyscrasias. 71
The anaplastic lymphoma kinase in the pathogenesis of cancer 68
The battle against ALK resistance: successes and setbacks. 66
Maspin and mammaglobin genes are specific markers for RT-PCR detection of minimal residual disease in patients with breast cancer 65
RHO Family GTPases in the Biology of Lymphoma 65
Modulation of doxorubicin resistance by the glucose 6-phosphate dehydrogenase activity 62
Molecular and clinical remissions in multiple myeloma: role of autologous and allogeneic transplantation of hematopoietic cells. 61
Frequent mutations of FBXO11 highlight BCL6 as a therapeutic target in Burkitt lymphoma 59
DNA repair mechanisms that promote insertion-deletion events during immunoglobulin gene diversification 57
Simple and Rapid InVivo Generation of Chromosomal Rearrangements using CRISPR/Cas9 Technology 56
Modeling lung cancer evolution and preclinical response by orthotopic mouse allografts 56
ALK inhibitors increase ALK expression and sensitize neuroblastoma cells to ALK.CAR-T cells 54
Reduced-intensity conditioning followed by allografting of hematopoietic cells can produce clinical and molecular remissions in patients with poor-risk hematologic malignancies. 53
ALK peptide vaccination restores the immunogenicity of ALK-rearranged non-small cell lung cancer 50
Liposome-encapsulated doxorubicin reverses drug resistance by inhibiting P-glycoprotein in human cancer cells. 49
The Tyrosine Phosphatase SHP2 Interacts with NPM-ALK and Regulates Anaplastic Lymphoma Cell Growth and Migration. 46
Modulation of doxorubicin resistance by the glucose 6-phosphate dehydrogenase activity 45
Mutational activation of N- and K-ras oncogenes in plasma cell dyscrasias. 45
Nonmyeloablative conditioning followed by hematopoietic cell allografting and donor lymphocyte infusions for patients with metastatic renal and breast cancer 45
Molecular remission after myeloablative allogeneic stem cell transplantation predicts a better relapse-free survival in patients with multiple myeloma. 44
Qualitative and quantitative polymerase chain reaction detection of the residual myeloma cell contamination after positive selection of CD34+ cells with small- and large-scale Miltenyi cell sorting system. 40
Targeting CCR7-PI3Kγ overcomes resistance to tyrosine kinase inhibitors in ALK-rearranged lymphoma 39
Effects of blocking CD24 and CD47 'don't eat me' signals in combination with rituximab in mantle-cell lymphoma and chronic lymphocytic leukaemia 34
Genomic Profiling Identifies Putative Pathogenic Alterations in NSCLC Brain Metastases 34
Regulation of CD45 phosphatase by oncogenic ALK in anaplastic large cell lymphoma 31
Review: biological implications of oncogenic rearrangements in non-small cell lung cancer 22
Totale 6.505
Salva come PNG Salva come JPEG
Categoria #
all - tutte 19.904
article - articoli 0
book - libri 0
conference - conferenze 822
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 20.726
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020309 0 0 0 0 0 0 0 0 108 71 72 58
2020/2021662 42 48 62 27 67 31 50 32 77 99 53 74
2021/2022800 42 45 33 53 28 30 90 40 30 76 177 156
2022/20231.037 131 108 27 106 77 253 88 64 89 23 45 26
2023/2024499 64 80 34 28 40 80 6 38 7 34 32 56
2024/20251.167 14 84 41 152 372 190 119 167 28 0 0 0
Totale 6.505